News Archive

Renalytix AI/EKF Diagnostics win at the AIM Awards 2019

11 October 2019

Congratulations Renalytix AI/EKF Diagnostics for winning the AIM Transaction of the Year at the AIM Awards 2019.

The AIM Transaction of the Year Award is awarded to a company that has been transformed by a single financial or commercial transaction during the period under review. This is an award given to recognise a significant achievement by a company in transforming itself and thereby creating significant shareholder value.

The AIM Awards scrutinises recent joiners and more established companies on AIM, as well as the advisers and commentators, to identify the stars of the last twelve months across ten categories. 


Picture shows, left to right: Louise Minchin, awards presenter; Marcus Stuttard, Head of AIM, London Stock Exchange; Christopher Mills, Chairman, EKF Diagnostics plc; Fergus Fleming, CTO, Renalytix AI plc; Julian Baines, CEO, Renalytix AI plc (winner); Simon Fine, CEO, Shore Capital; and Scott Knight, Head of Audit, BDO LLP.

For more information please visit:


Who We Work With